Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
ImmuneOnco Biopharmaceuticals (Shanghai) (IOB HK)
Watchlist
8
Analysis
Health Care
•
China
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
ImmuneOnco Biopharmaceuticals (Shanghai)
•
06 Aug 2024 07:45
•
Broker
ImmuneOnco (1541 HK) - Achieved Significant Overseas Licensing Partnership
Successful overseas licensing of PD-L1xVEGF bsAb and anti-CTLA4 mAb. ImmuneOnco reached an agreement with SynBioTx (a wholly - owned subsidiary of...
CMB International
Follow
187 Views
Share
bearish
•
ImmuneOnco Biopharmaceuticals (Shanghai)
•
14 Jan 2024 09:34
China Healthcare Weekly (Jan.12) - Mainstream R&D Trend, Innovent, BeiGene, Sirnaomics, ImmuneOnco
If we look at mainstream R&D trend, the choices made by companies like Innovent/BeiGene are reasonable. Investment value of Sirnaomics is low....
Xinyao (Criss) Wang
Follow
487 Views
Share
bullish
•
UBTech Robotics
•
18 Feb 2024 11:00
HSCI Index Rebalance: 25 Adds, 29 Deletes & Changes to Southbound Stock Connect
There are 25 adds and 29 deletes for the HSCI in March. 21 stocks will be added to Stock Connect while 27 will be deleted. Positions via the...
Brian Freitas
Follow
724 Views
Share
bullish
•
Shriram Finance
•
07 Jan 2024 05:10
Index Rebalance & ETF Flow Recap: HSCEI, HSCI, KRX New Deal, NIFTY50, NEXT50, CNXBANK
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
805 Views
Share
bullish
•
WuXi XDC Cayman
•
03 Jan 2024 05:00
HSCI Index Rebalance Preview and Stock Connect: Potential Changes in March
There could be nearly 58 adds/deletes for the HSCI in September. That will trigger changes to the Southbound Stock Connect list and increase flows...
Brian Freitas
Follow
985 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x